Accreditation/Credit Designation

Physicians’ Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians’ Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.0 Contact Hours.

Acknowledgment of Support

This activity is supported by an educational grant from Amgen, Inc.

Refining Our Osteoporosis Treatment and Prevention Practices

Release Date: August 23, 2021
Expiration Date: August 23, 2022

Activity Overview

This online, on-demand virtual symposium brings together renowned experts in screening guidelines and management of osteoporosis. In this educational program, these experts will take on the viewpoint of obstetrician-gynecologists, from the patient impact of osteoporosis to innovative strategies that can improve care, including pharmacologic and nonpharmacologic options. To put expert discussions into practice, essential elements and resources for personalized management will be presented with a focus on recent osteoporosis treatment guideline recommendations and the newest evidence on anabolic and anticatabolic agents.

This educational activity is an archive of the live virtual symposium held on July 24, 2021.

Acknowledgement of Commercial Support

This activity is supported by an educational grant from Amgen, Inc.

Instructions for This Activity and Receiving Credit

  1. Complete the activity (including pre- and post-activity assessments).
  2. Answer the evaluation questions.
  3. Request credit using the drop-down menu.

You may immediately download your certificate.

Target Audience

This educational program is directed toward OB/GYNs. PCPs, NPs, and PAs who treat women with osteoporosis are also invited to participate.

Learning Objectives

At the conclusion of this activity, you should be better prepared to:

  • Discuss practical screening approaches in the primary care setting for patients at risk for osteoporosis
  • Outline guideline recommendations for use of osteoporosis therapies
  • Assess the efficacy and safety of current and emerging osteoporosis therapies
  • Develop multidisciplinary, individualized treatment plans for osteoporosis care in patients with complex needs

Faculty, Staff, and Planners’ Disclosures

The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible entities.


John P. Bilezikian, MD, PhD (hon)
John P. Bilezikian, MD, PhD (hon)
Dorothy L. and Daniel H. Silberberg Professor of Medicine
Vice-Chair, Department of Medicine
International Education and Research
Chief Emeritus, Division of Endocrinology
Vagelos College of Physicians & Surgeons
Columbia University
New York, NY

Disclosures: Consultant: Amgen, Amolyt, Agios, Ascendis, Takeda Pharmaceuticals, Radius Pharmaceuticals, Shire, Ultragenyx; Other: Regeneron (DSMB)

E. Michael Lewiecki, MD
E. Michael Lewiecki, MD
Director, New Mexico Clinical Research & Osteoporosis Center
Clinical Assistant Professor of Medicine
University of New Mexico Health Sciences Center
Albuquerque, NM

Disclosures: Grant Research Support (paid to New Mexico Clinical Research & Osteoporosis Center): Amgen, Blindex, Mereo, Radius; Consultant: Amgen, Radius; Speakers’ Bureau: Radius Other: Served on guideline committees for the International Society for Clinical Densitometry, National Osteoporosis Foundation, American Association of Clinical Endocrinologists, and North American Menopause Society

Andrea J. Singer, MD, FACP, CCD
Andrea J. Singer, MD, FACP, CCD
Director, Women's Primary Care
Director, Bone Densitometry
Department of Obstetrics and Gynecology
MedStar Georgetown University Hospital
Washington, DC

Disclosures: Grant research support: (paid to Georgetown University and MedStar Health): Radius Health, UCB; Consultant: Agnovos, Amgen, Eli Lilly, Merit, Radius Health, UCB; Speakers’ Bureau: Amgen, Eli Lilly, Radius Health; Other: Board of Trustees and Chief Medical Officer, National Osteoporosis Foundation

PER® mitigated all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any company that provided commercial support for this activity.

Login or Register to Start Activity

Please use the form below to Register or Log In to begin Activity.

*Required Fields
Calendar of Events
Filter By